University of Minnesota
Minneapolis, Minnesota, 55455, United States
NCT Number: NCT00000290
The purpose of this study is to determine the HPA axis and adrenergic system activation in response to cocaine administration.
Looking for future studies?
Notify Me20 year–45 year
Male
Interventional
Phase 1
Minneapolis, Minnesota, 55455, United States
The goal of this study was to investigate the role of sympathetic-adrenal medullary (SAM) and hy0pothalamo-pituitary-adrenal (HPA) systems in mediating the addictive effects of cocaine. A toal of 6 male subjects were enrolled for this 5 day inpatient study. Subjects were assigned to either cocaine (32mg /70kg iv) or placebo (saline iv) treatment during the first experimental sessions and were crossed over to the alternative treatment during the second experimental session. Endpoints that were followed during the experimental sessions included neuroendocrine (serum epinephrine, norepinephrine and cortisol levels), physological (heart rate/blood pressure, EKG) and subjective measures (Beck Depression Inventory, Craving Questionnaire). We hypothesized that cocaine administration would lead to increased blood levels of norpinephrine, epinephrine and cortisol in cocaine dependent subjects.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Males between the ages of 20-45. History of smoked or intravenous cocaine use on the average of at least once a week over a 6 month period. Current history of good health and normal EKG.
Exclusion criteria
History of suicide attempt, bipolar disorder, schizophrenia, or generalized anxiety disorder. Current problem with major depressive disorder. Current use of alcohol or other drugs on a daily basis. History of major medical illnesses. Currently on parole, probation or a legal history of violence. Treatment for chemical dependency within the past 6 months. History of sensitivity to tricyclic compounds or other prescription drugs. Use of any psychotropic drugs including MAOIs in the past 6 months.
National Institute on Drug Abuse (NIDA)
Nih
Stress Hormones and Human Cocaine Use
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02037126
Chemically-Induced Disorders, Cocaine-Related Disorders
Birmingham, Alabama, United States
View Trial DetailsNCT04155632
Chemically-Induced Disorders, Cocaine-Related Disorders
Charleston, South Carolina, United States
View Trial DetailsNCT02773212
Anhedonia, Chemically-Induced Disorders
Chicago, Illinois, United States
View Trial DetailsNCT03953612
Chemically-Induced Disorders, Cocaine-Related Disorders
New Haven, Connecticut, United States
View Trial Details